Calamos Advisors’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-11,780
Closed -$422K – 715
2020
Q1
$422K Hold
11,780
– – ﹤0.01% 643
2019
Q4
$600K Buy
11,780
+280
+2% +$13.3K ﹤0.01% 698
2019
Q3
$505K Hold
11,500
– – ﹤0.01% 698
2019
Q2
$574K Hold
11,500
– – ﹤0.01% 690
2019
Q1
$442K Buy
+11,500
New +$415K ﹤0.01% 615
2013
Q4
– Sell
-156,414
Closed -$3.23M – 629
2013
Q3
$3.23M Buy
+156,414
New +$2.99M 0.02% 349

Other funds holding BRKR

Calamos Advisors's BRKR Position: Q2 2020 in Review

Calamos Advisors sold out of Bruker (BRKR) in Q2 2020, closing a stake of 11,780 shares — an estimated $422K sold.

Calamos Advisors first reported a position in BRKR in Q3 2013 and held it in 6 quarters. The position peaked at $3.23M in Q3 2013. 227 funds tracked by Wall St. Rank hold BRKR as of Q2 2020.

  • Calamos Advisors reported no remaining Bruker position as of Q2 2020 after selling out during the quarter.
  • Calamos Advisors sold 11,780 Bruker shares in Q2 2020, an estimated $422K.
  • Calamos Advisors first reported a position in Bruker in Q3 2013 and held it in 6 quarters.
  • Calamos Advisors's Bruker position peaked at $3.23M in Q3 2013.
  • 227 funds tracked by Wall St. Rank held Bruker as of Q2 2020.

Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.